Boston Scientific, a medical device manufacturer based in Marlborough announced in June that David Wichmann has been elected to its board of directors, effective immediately. According to the press release, Wichmann recently served as CEO of global conglomerate UnitedHealth Group from 2017 to 2021.
- Previous engagements: Prior to joining UnitedHealth Group, Wichmann was a partner at the global accounting firm Arthur Andersen & Co. He has served on the boards of UnitedHealth Group and Tennant Co. and holds a bachelor’s degree in accounting from Illinois State University.
- Expertise: “From his experience leading one of the largest health care organizations in the world, Dave has unique insights about opportunities to improve patient outcomes while also taking costs out of the health care system,” Mike Mahoney, CEO, and chairman of the board at Boston Scientific said in the release.
- Innovative medical solutions: Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, they advance science for life by providing a broad range of high-performance solutions that address the patient’s needs and reduce the cost of healthcare.
- Enhanced growth: His career at UnitedHealth Group spans 23 years in roles of increasing responsibility leading the growth, diversification and performance of the company’s domestic and international businesses, including president, chief financial officer, and head of operations and commercial markets.
- Inclusive environment: Boston Scientific goes beyond its mission of transforming patient lives by investing in the future and the well-being of its employees and their planet. The commitment to sustainability is evident in its Newsweek ranking as the 16th greenest company in the U.S. It also strives to foster a diverse and inclusive work environment and provide opportunities for their 38,000+ employees around the world to serve in their local communities.
